Subclinical-Hypothyroidism: A Pathology in Evolution.

J Coll Physicians Surg Pak 2019 Feb;29(2):150-158

Department of Chemical Pathology and Clinical Endocrinology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan.

Subclinical-hypothyroidism is identified as suboptimal thyroid hormonal production associated with mild TSH (thyroid stimulating hormone) elevation. Though several non-thyroidal illness in the later stages, medications and dietary supplements may resemble SCH (subclinical-hypothyroidism), but mild persistent subnormal thyroidal pathologies are usually termed as SCH. This review briefly describes the various cardiovascular risk associations with subclinicalhypothyroidism and attempts to provide an insight into the risk and benefit association, which a patient faces once treated for SCH.

Download full-text PDF

Source
https://www.jcpsp.pk/archive/2019/Feb2019/13.pdf
Publisher Site
http://dx.doi.org/10.29271/jcpsp.2019.02.150DOI Listing
February 2019
30 Reads
0.439 Impact Factor

Publication Analysis

Top Keywords

subnormal thyroidal
4
persistent subnormal
4
thyroidal pathologies
4
pathologies termed
4
sch review
4
termed sch
4
mild persistent
4
subclinical-hypothyroidism mild
4
stages medications
4
illness stages
4
medications dietary
4
dietary supplements
4
sch subclinical-hypothyroidism
4
supplements resemble
4
review describes
4
describes cardiovascular
4
benefit association
4
risk benefit
4
association patient
4
patient faces
4

Similar Publications